| Page 34 | Kisaco Research

VP, Head of Intellectual Property, Neumora Therapeutics

"Well organized conference with practical, relevant and meaningful panel discussions."

Partner, Quinn Emanuel Urquhart & Sullivan. LLP

"Excellent event with timely content for both in-house practitioners and outside counsel.  Great mix of people engaged in making the conference interesting and worthwhile."

 

David Coleman

Chief Product Officer
iov42 I Interu

David Coleman

Chief Product Officer
iov42 I Interu

David Coleman

Chief Product Officer
iov42 I Interu
 

Anna Roberts

Head of Market Development
iov42 I Interu

Anna Roberts

Head of Market Development
iov42 I Interu

Anna Roberts

Head of Market Development
iov42 I Interu
 

Brennan John

Director, Revenue Cycle
Intermountain Health

Brennan John

Director, Revenue Cycle
Intermountain Health

Brennan John

Director, Revenue Cycle
Intermountain Health
 

Ismet Sharich

Patient Access Director
Riverside Healthcare

Ismet Sharich

Patient Access Director
Riverside Healthcare

Ismet Sharich

Patient Access Director
Riverside Healthcare
 

Howard Kung

Senior Director, Revenue Cycle
Mayo Clinic

Howard Kung

Senior Director, Revenue Cycle
Mayo Clinic

Howard Kung

Senior Director, Revenue Cycle
Mayo Clinic